Clinical data Strategic rationale UroLift Spin Capital allocation strategy Revenue / revenue growth / revenues Value creation Market dynamics Constant currency growth Guiding principles Year- over-year growth Cash flow from operations Tariff impact / tariffs Foreign exchange impact Gross margin Strategic update / strategy Guidance / updated financial guidance Operating margin Interventional business Unlock value Future outlook Patient outcomes / patient care Cost inflation NewCo Core business Barrigel Adjusted earnings per share Volume- based procurement In line with expectations Better than expected Expressions of interest Titan SGS stapler Operational excellence / operational execution Parallel paths Acquisition (Vascular Intervention acquisition) Focused strategic direction Simplified manufacturing footprint Constant currency basis FreeSolve technology Investor event Sequential improvement Potential sale of Newco Long- term growth Integration activities / integration Shareholder value / maximizing shareholder value Clinical data Strategic rationale UroLift Spin Capital allocation strategy Revenue / revenue growth / revenues Value creation Market dynamics Constant currency growth Guiding principles Year- over-year growth Cash flow from operations Tariff impact / tariffs Foreign exchange impact Gross margin Strategic update / strategy Guidance / updated financial guidance Operating margin Interventional business Unlock value Future outlook Patient outcomes / patient care Cost inflation NewCo Core business Barrigel Adjusted earnings per share Volume- based procurement In line with expectations Better than expected Expressions of interest Titan SGS stapler Operational excellence / operational execution Parallel paths Acquisition (Vascular Intervention acquisition) Focused strategic direction Simplified manufacturing footprint Constant currency basis FreeSolve technology Investor event Sequential improvement Potential sale of Newco Long- term growth Integration activities / integration Shareholder value / maximizing shareholder value
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
Clinical data
Strategic rationale
UroLift
Spin
Capital allocation strategy
Revenue / revenue growth / revenues
Value creation
Market dynamics
Constant currency growth
Guiding principles
Year-over-year growth
Cash flow from operations
Tariff impact / tariffs
Foreign exchange impact
Gross margin
Strategic update / strategy
Guidance / updated financial guidance
Operating margin
Interventional business
Unlock value
Future outlook
Patient outcomes / patient care
Cost inflation
NewCo
Core business
Barrigel
Adjusted earnings per share
Volume-based procurement
In line with expectations
Better than expected
Expressions of interest
Titan SGS stapler
Operational excellence / operational execution
Parallel paths
Acquisition (Vascular Intervention acquisition)
Focused strategic direction
Simplified manufacturing footprint
Constant currency basis
FreeSolve technology
Investor event
Sequential improvement
Potential sale of Newco
Long-term growth
Integration activities / integration
Shareholder value / maximizing shareholder value